Literature DB >> 19193605

Extracellular ATP in the immune system: more than just a "danger signal".

Alain Trautmann1.   

Abstract

Extracellular adenosine 5'-triphosphate (eATP) is ubiquitously used for cell-to-cell communication. The low concentration of eATP ([eATP]) that exists in a "halo" surrounding resting cells signals the presence of neighboring living cells. Transient increases in [eATP] are used for basic physiological signaling, namely, in the nervous and vascular systems. Larger increases in [eATP] that are associated with cell death serve as a key "danger" signal in inflammatory processes. Two studies now point to roles for ATP in the immune system: providing a costimulatory signal to T cells and driving the differentiation of intestinal T helper 17 (T(H)17) cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19193605     DOI: 10.1126/scisignal.256pe6

Source DB:  PubMed          Journal:  Sci Signal        ISSN: 1945-0877            Impact factor:   8.192


  161 in total

Review 1.  Purinergic signaling and human immunodeficiency virus/acquired immune deficiency syndrome: From viral entry to therapy.

Authors:  Daniela F Passos; Maria Rosa C Schetinger; Daniela Br Leal
Journal:  World J Virol       Date:  2015-08-12

Review 2.  The Purinergic System as a Pharmacological Target for the Treatment of Immune-Mediated Inflammatory Diseases.

Authors:  Luca Antonioli; Corrado Blandizzi; Pál Pacher; György Haskó
Journal:  Pharmacol Rev       Date:  2019-07       Impact factor: 25.468

3.  Identification of an Arabidopsis plasma membrane-located ATP transporter important for anther development.

Authors:  Benjamin Rieder; H Ekkehard Neuhaus
Journal:  Plant Cell       Date:  2011-05-03       Impact factor: 11.277

Review 4.  How the Respiratory Epithelium Senses and Reacts to Influenza Virus.

Authors:  Kambez H Benam; Laura Denney; Ling-Pei Ho
Journal:  Am J Respir Cell Mol Biol       Date:  2019-03       Impact factor: 6.914

5.  P2X1 Selective Antagonists Block HIV-1 Infection through Inhibition of Envelope Conformation-Dependent Fusion.

Authors:  Alexandra Y Soare; Hagerah S Malik; Natasha D Durham; Tracey L Freeman; Raymond Alvarez; Foramben Patel; Namita Satija; Chitra Upadhyay; Catarina E Hioe; Benjamin K Chen; Talia H Swartz
Journal:  J Virol       Date:  2020-02-28       Impact factor: 5.103

6.  Novel method for real-time monitoring of ATP release reveals multiple phases of autocrine purinergic signalling during immune cell activation.

Authors:  C Ledderose; Y Bao; J Zhang; W G Junger
Journal:  Acta Physiol (Oxf)       Date:  2014-12-29       Impact factor: 6.311

7.  Biglycan, a danger signal that activates the NLRP3 inflammasome via toll-like and P2X receptors.

Authors:  Andrea Babelova; Kristin Moreth; Wasiliki Tsalastra-Greul; Jinyang Zeng-Brouwers; Oliver Eickelberg; Marian F Young; Peter Bruckner; Josef Pfeilschifter; Roland M Schaefer; Hermann-Josef Gröne; Liliana Schaefer
Journal:  J Biol Chem       Date:  2009-07-15       Impact factor: 5.157

8.  Ecto-nucleoside triphosphate diphosphohydrolase 7 controls Th17 cell responses through regulation of luminal ATP in the small intestine.

Authors:  Takashi Kusu; Hisako Kayama; Makoto Kinoshita; Seong Gyu Jeon; Yoshiyasu Ueda; Yoshiyuki Goto; Ryu Okumura; Hiroyuki Saiga; Takashi Kurakawa; Kayo Ikeda; Yuichi Maeda; Jun-ichi Nishimura; Yasunobu Arima; Koji Atarashi; Kenya Honda; Masaaki Murakami; Jun Kunisawa; Hiroshi Kiyono; Meinoshin Okumura; Masahiro Yamamoto; Kiyoshi Takeda
Journal:  J Immunol       Date:  2012-12-14       Impact factor: 5.422

9.  The P2 receptor antagonist PPADS abrogates LPS-induced neutrophil migration in the murine air pouch via inhibition of MIP-2 and KC production.

Authors:  Filip Kukulski; Fethia Ben Yebdri; Fariborz Bahrami; Sébastien A Lévesque; Mireia Martín-Satué; Jean Sévigny
Journal:  Mol Immunol       Date:  2009-11-03       Impact factor: 4.407

Review 10.  Extracellular nucleotides as negative modulators of immunity.

Authors:  Francesco Di Virgilio; Jean-Marie Boeynaems; Simon C Robson
Journal:  Curr Opin Pharmacol       Date:  2009-07-21       Impact factor: 5.547

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.